Because of the increasing prevalence of VRE infection and the limited treatment options available, we anticipate that management of VRE UTIs will continue to be challenging for the clinician.

In conclusion, Clostridioides difficile infection remains a critical challenge in healthcare, with recurrence being a major complication. Current treatments like fidaxomicin and vancomycin ...